Upload Avatar (500 x 500)
Youquan Bu
Basic Medical Sciences
Chongqing Medical University
Chongqing
Language: Chinese, English
Cancer
Oncology
Molecular
Bioinformatics
Tumor
Genomics
Proteomics
Biomarkers
Therapy
Research
Areas of Focus
- Molecular Oncology
- Cancer Bioinformatics
Work Experience
- Director of the Department of Biochemistry and Molecular Biology, Chongqing Medical University
- Director of the Molecular Medicine and Oncology Research Center
- Executive Director of Chongqing Biochemistry and Molecular Biology Society
- Director of Chongqing Cell Biology Society
Academic Background & Achievements
- 2005-2007: Nationally funded study in Japan at Chiba Cancer Center
- Member of the Chinese Society of Biochemistry and Molecular Biology
- Editorial board member of 'Chinese Journal of Biochemistry and Molecular Biology'
- Associate Editor of 'Genes & Diseases'
- Editorial board member of 'Encyclopedia of Chinese Medicine'
Publications
- B-Myb accelerates colorectal cancer progression through reciprocal feed-forward transactivation of E2F2., Fan X, Wang Y, Jiang T, Liu T, Jin Y, Du K, Niu Y, Zhang C, Liu Z, Lei Y, Bu Y., 2021
- E2F2 promotes lung adenocarcinoma progression through B-Myb- and FOXM1-facilitated core transcription regulatory circuitry., Du K, Sun S, Jiang T, Liu T, Zuo X, Xia X, Liu X, Wang Y, Bu Y., 2022
- Transfer RNA-derived small RNAs (tsRNAs): Versatile regulators in cancer., Xu D, Qiao D, Lei Y, Zhang C, Bu Y, Zhang Y., 2022
- The gene pair PRR11 and SKA2 shares a NF-Y-regulated bidirectional promoter and contributes to lung cancer development., Wang Y, Zhang Y, Zhang C, Weng H, Li Y, Cai W, Xie M, Long Y, Ai Q, Liu Z, Du G, Wang S, Niu Y, Song F, Ozaki T, Bu Y., 2015
- PRR11 is a novel gene implicated in cell cycle progression and lung cancer., Ji Y, Xie M, Lan H, Zhang Y, Long Y, Weng H, Li D, Cai W, Zhu H, Niu Y, Yang Z, Song F, Bu Y., 2013
Awards
- Chongqing Science and Technology Progress Third Prize
